Xtx Topco LTD Clovis Oncology, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $59,746 - $162,167	56,901 Added 84.99%	123,853 $147,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $52,790 - $248,030	-83,794 Reduced 55.59%	66,952 $121,000
Q1 2022 May 13, 2022	BUY	$1.43 - $3.14 $185,651 - $407,653	129,826 Added 620.58%	150,746 $305,000
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $56,484 - $99,579	20,920 New	20,920 $57,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.